Marc Thomas

Marc Thomas is an Associate Researcher at Numab Therapeutics AG since December 2022, following a role as a Master Thesis Student in protein engineering at the University of Zurich from July 2021 to July 2022. Marc holds a Master's degree in Biochemistry from Heidelberg University, completed in September 2022, and a Bachelor's degree in Biochemistry from the University of Zurich, awarded in 2020. Prior experience includes a part-time position as a Barista at Luus Muus from September 2017 to September 2020 and an internship in the Life Actuarial Department at PartnerRe in July 2014.